Sangamo Therapeutics files Chapter 11; stock now trades on OTCID Basic under SGMOQ; auditor EY terminated

SANGAMO THERAPEUTICS, INC

Filed voluntary Chapter 11 petition (Case No. 26-10989) on June 24, 2026.
Common stock began trading on OTCID Basic Market under symbol SGMOQ on June 24, 2026.
Nasdaq delisting appeal pending; stock suspended from Nasdaq since May 5, 2026.
Audit committee terminated Ernst & Young as independent auditor on June 25, 2026.
No new auditor engaged; EY's reports included going-concern explanatory paragraph.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.